InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Tuesday, 11/07/2017 3:16:15 PM

Tuesday, November 07, 2017 3:16:15 PM

Post# of 345744
P3.02c-051 A Pre-Treatment Serum Test Based on Complement and IL-10 Pathways Identifies Patients Benefiting from the Addition of Bavituximab to Docetaxel

Topic: IT

David Gerber

Joanna Roder
Nikoletta Kallinteris
Leora Horn
Gyorgy Losonczy
Ronald Natale
Min Tang
Heinrich Roder
Joseph Shan
Rachel Sanborn

If known pls delete

http://www.jto.org/article/S1556-0864(16)33087-8/fulltext
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News